Emily Luisa Hill - 31 Mar 2022 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Issuer symbol
PTCT
Transactions as of
31 Mar 2022
Net transactions value
-$298,824
Form type
4
Filing time
01 Apr 2022, 16:20:06 UTC
Previous filing
03 Feb 2022
Next filing
09 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale $298,824 -7,910 -21% $37.78 29,259 31 Mar 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2022.
F2 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $37.30 to $38.20 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.